Inflammation

Items 1-10 of 23

Page
per page
Set Descending Direction
  1. anti-Caspase-11 (mouse), mAb (4E11)
    AG-20T-0140
    AG-20T-0140-C100100 µg
    CHF 430.00
    Western blot using anti-Caspase-11 (mouse), mAb (4E11) (Prod. No. AG-20T-0140) detecting endogenous caspase-11 in mouse spleen and lymph node as two bands of 43 and 38 kDa after exposure to LPS.
  2. anti-Caspase-11 (mouse), mAb (8A5)
    AG-20T-0139
    AG-20T-0139-C100100 µg
    CHF 430.00
    Western blot using anti-Caspase-11 (mouse), mAb (8A5) (Prod. No. AG-20T-0139) detecting endogenous caspase-11 in mouse spleen and lymph node as two bands of 43 and 38 kDa after exposure to LPS.
  3. anti-NF-κB (p65), pAb
    AG-25T-0004
    AG-25T-0004-R100100 µl
    CHF 290.00
  4. anti-PIDD (mouse), mAb (Lise-1)
    AG-20B-0038
    AG-20B-0038-C100100 µg
    CHF 460.00
    Mouse PIDD is detected in primary MEF cells using anti-PIDD (mouse), mAb (Lise-1) (Prod. N°AG-20B-0038). Method:: Cell extracts from mouse embryo fibroblasts (MEFs) either from WT (A-B) or  PIDD KO cells (C-D) were separated by SDS-PAGE under
  5. anti-PIDD, pAb (AL233)
    AG-25B-0015
    AG-25B-0015-C05050 µg
    CHF 270.00
    anti-PIDD, pAb (AL233)
  6. anti-Poly(ADP-ribose) [PAR], mAb (10H)
    AG-20T-0001
    AG-20T-0001-C05050 µg
    CHF 190.00
    AG-20T-0001-C100100 µg
    CHF 290.00
    AG-20T-0001-M0011 mg
    CHF 860.00
    anti-Poly(ADP-ribose) [PAR], mAb (10H)
  7. anti-TNF-α (mouse), mAb (blocking) (V1q) (preservative free)
    AG-20B-0081PF
    AG-20B-0081PF-C100100 µg
    CHF 360.00
    AG-20B-0081PF-C500500 µg
    CHF 1'080.00
    anti-TNF-α (mouse), mAb (blocking) (V1q) (preservative free)
  8. CD40 (human):Fc (human) (rec.)
    AG-40B-0083
    AG-40B-0083-C05050 µg
    CHF 300.00
    AG-40B-0083-30503 x 50 µg
    CHF 600.00
  9. Fas (human):Fc (human) (rec.)
    AG-40B-0082
    AG-40B-0082-C05050 µg
    CHF 300.00
    AG-40B-0082-30503 x 50 µg
    CHF 600.00
  10. FasL (human) (multimeric) (rec.)
    AG-40B-0130
    AG-40B-0130-C01010 µg
    CHF 380.00
    AG-40B-0130-30103 x 10 µg
    CHF 760.00
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of FasL (human) (multimeric) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Prod. No.

Items 1-10 of 23

Page
per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.